BMO Capital raises Lemonade stock price target to $23 on premium retention

BMO Capital raised its price target for Lemonade (LMND) to $23 from $15, while maintaining an Underperform rating, citing the company's accelerated shift to retaining approximately 80% of gross premiums, up from 45%, ahead of prior modeling. This operational improvement, supported by strong Q1 2025 financial results including revenue and gross profit beats, and a significant reduction in reinsurance quota share from 55% to 20%, indicates enhanced underwriting capabilities. Despite these positive developments and LMND's 166% stock return over the past year, trading currently at $45.03, the sustained Underperform ratings from BMO and Keefe, Bruyette & Woods suggest continued analyst skepticism regarding valuation or long-term growth prospects.

Analysis

Lemonade Inc. is implementing a significant strategic shift by increasing its gross premium retention to approximately 80% from a previous 45%, a move that BMO Capital notes is occurring ahead of its own projections. This change, underpinned by a reduction in the reinsurance quota share from 55% to 20%, signals management's growing confidence in its underwriting capabilities and diversification. The operational pivot is supported by strong Q1 2025 financial results, where Lemonade surpassed expectations with revenue of $151.2 million against a $145.92 million forecast and an EPS beat at -$0.86 versus an anticipated -$0.92. Furthermore, adjusted gross profit reached $46 million, well above the $37 million consensus. Despite these positive fundamentals and a 166% stock return over the past year, a notable valuation disconnect persists. While analysts at BMO and Keefe, Bruyette & Woods raised their price targets to $23 and $26 respectively, they both maintain 'Underperform' ratings, suggesting the current stock price of $45.03 is significantly overvalued in their models. This contrasts with JMP's 'Market Outperform' rating and $60 price target, which highlights success in auto insurance expansion and the company's accelerating in-force premium growth for six consecutive quarters.

Key Decisions for Investors

• Investors should weigh the company's demonstrated operational execution, including strong Q1 results and accelerated premium retention, against the significant valuation concerns highlighted by the 'Underperform' ratings from BMO and KBW, whose price targets are nearly 50% below the current market price.
• Monitor Lemonade's loss ratios and capital adequacy closely in upcoming quarters, as the reduced reliance on reinsurance places a greater emphasis on the performance of its own underwriting models.
• Consider the wide divergence in analyst price targets ($23 to $60) as an indicator of high uncertainty, suggesting that positions in LMND carry elevated risk and may be more suitable for investors with a high tolerance for volatility.
• For those with a bullish outlook aligned with JMP, continued acceleration in in-force premium growth and successful expansion in new product lines like auto insurance are key validation points to watch for.